AstraZeneca, in collaboration with the University of Oxford, has acknowledged that its COVID-19 vaccine carries the risk of causing a rare side effect known as Thrombosis with Thrombocytopenia Syndrome (TTS), according to a report by The Telegraph. The pharmaceutical company is facing a lawsuit alleging that its vaccine has led to fatalities and serious injuries among recipients.
Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News